Viewing Study NCT03471260


Ignite Creation Date: 2025-12-25 @ 2:04 AM
Ignite Modification Date: 2026-02-10 @ 10:40 PM
Study NCT ID: NCT03471260
Status: RECRUITING
Last Update Posted: 2025-10-03
First Post: 2018-03-02
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Ivosidenib and Venetoclax With or Without Azacitidine in Treating Patients With IDH1 Mutated Hematologic Malignancies
Sponsor: M.D. Anderson Cancer Center
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module